TRANSFORM-1
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
TRANSFORM-1
Jul 2, 2024, 08:18 |
Blog
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…
Jun 17, 2024, 07:05 |
Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
Jun 16, 2024, 14:10 |
Insight
Naveen Pemmaraju: TRANSFORM-1 results randomized Phase 3 clinical trial at EHA24
Naveen Pemmaraju shared on X: "Honored to present at EHA24 today the TRANSFORM-1 results from…
All:
3
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube